TGFB1 and aneurysm: Based on the obtained results, the authors conclude that modulation of the TGF-β and MAPK signaling pathways in aneurysm patients may contribute to inflammatory responses, extracellular matrix (ECM) degradation, and apoptosis of vascular smooth muscle cells (SMCs) ultimately leading to vessel wall damage and potential rupture [23].